LumiraDx Limited
NASDAQ: LMDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Veronique Ameye EMBA,
- Employees
- 1,210
- Headquarters
- London, United Kingdom
- IPO year
- 2021
- Market cap
- $5.1M
- Website
- https://www.lumiradx.com
Loading LMDX…
Loading profile data…Frequently asked questions about LMDX
What does LumiraDx Limited (LMDX) do?
LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions. Its core mission is to revolutionize community healthcare by equipping medical professionals with crucial diagnostic insights directly at the patient's side. The company develops and commercializes a sophisticated diagnostic platform, offering a diverse array of test...
Where does LMDX trade?
LumiraDx Limited (LMDX) trades on the NASDAQ Global Market.
What sector is LMDX in?
LumiraDx Limited (LMDX) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of LumiraDx Limited?
Veronique Ameye EMBA, is the chief executive officer of LumiraDx Limited (LMDX).
Where is LumiraDx Limited headquartered?
LumiraDx Limited is headquartered in United Kingdom.
Does LMDX pay a dividend?
LumiraDx Limited (LMDX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LMDX go public?
LumiraDx Limited (LMDX) completed its initial public offering in 2021.